Ruby Gadelrab and Jill Hagenkord are hoping to bridge the gap between technology and medicine, and help investors vet start-ups for potential red flags.
Not all problems are related to lying and cheating. In 2013, the Federal Drug Administration asked 23andMe to stop selling its health tests because the company couldn't prove they worked. It set 23andMe back two years while the companyGadelrab was working at genetics company Affymetrix when she met Hagenkord, whose background was in pathology and genomics.
Some of the books she recommends to tech entrepreneurs include Ezekiel Emanuel's "Reinventing American Health Care" and Otis Web Brawley's "How We Do Harm." She also tries to educate them on the challenges that doctors face. While there's a myth that all doctors are paternalistic and don't listen to their patients, the real problem is that the system requires them to spendand they don't have sufficient time to spend on holistic patient care.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Doctor calls for funding gun violence prevention researchWATCH: Dr. Roger Mitchell, Jr., Washington D.C. chief medical examiner, joins Morning_Joe to discuss the relationship between guns and public health.
Consulte Mais informação »
https://time.comBreaking news and analysis from TIME.com. Politics, world news, photos, video, tech reviews, health, science and entertainment news.
Consulte Mais informação »
https://time.comBreaking news and analysis from TIME.com. Politics, world news, photos, video, tech reviews, health, science and entertainment news.
Consulte Mais informação »
The elderly are the next big growth market for Chinese tech firmsPeople over 55 are now WeChat’s fastest-growing cohort
Consulte Mais informação »